troglitazone has been researched along with Starvation in 2 studies
Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.
Starvation: Lengthy and continuous deprivation of food. (Stedman, 25th ed)
Excerpt | Relevance | Reference |
---|---|---|
"Among three gastric cancer cell lines, MKN28, MKN45, and MKN74, only the most poorly differentiated MKN45 cells survived >36 h." | 1.31 | Remarkable tolerance of tumor cells to nutrient deprivation: possible new biochemical target for cancer therapy. ( Esumi, H; Izuishi, K; Kato, K; Kinoshita, T; Ogura, T, 2000) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fulgencio, JP | 1 |
Kohl, C | 1 |
Girard, J | 1 |
Pégorier, JP | 1 |
Izuishi, K | 1 |
Kato, K | 1 |
Ogura, T | 1 |
Kinoshita, T | 1 |
Esumi, H | 1 |
2 other studies available for troglitazone and Starvation
Article | Year |
---|---|
Troglitazone inhibits fatty acid oxidation and esterification, and gluconeogenesis in isolated hepatocytes from starved rats.
Topics: Animals; Caprylates; Carnitine O-Palmitoyltransferase; Cells, Cultured; Chromans; Coenzyme A Ligases | 1996 |
Remarkable tolerance of tumor cells to nutrient deprivation: possible new biochemical target for cancer therapy.
Topics: Antineoplastic Agents; Cell Survival; Chromans; Chromones; Culture Media, Serum-Free; Enzyme Activat | 2000 |